Skip to content

CDT

CDT Equity Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.19
−20.88%
Ask drillr

Year over year

Reported trailing growth

Revenue
—
EBITDA
+1368.0%
EBIT
+1034.2%
EPS
+45.1%
Free cash flow
+96.1%
Operating cash flow
—

Forward estimates

Based on analyst estimates

Revenue
—
EBITDA
—
EPS
—

Three-year CAGR

Revenue
—
EBITDA
—
EBIT
—
Net income
—
EPS
+98.1%
Free cash flow
-84.5%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026